Logo image of ECCV

EAGLE POINT CREDIT CO - ECC 5 3/8 01/31/29 (ECCV) Stock Fundamental Analysis

NYSE:ECCV - New York Stock Exchange, Inc. - US2698098850 - Currency: USD

23.4142  0 (-0.01%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ECCV. ECCV was compared to 0 industry peers in the Unkown industry. ECCV has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, ECCV is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ECCV had positive earnings in the past year.
ECCV had a negative operating cash flow in the past year.
ECCV had positive earnings in 4 of the past 5 years.
In the past 5 years ECCV reported 4 times negative operating cash flow.
ECCV Yearly Net Income VS EBIT VS OCF VS FCFECCV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M -400M

1.2 Ratios

Industry RankSector Rank
ROA -3.6%
ROE -5.15%
ROIC 6.48%
ROA(3y)1.32%
ROA(5y)6.59%
ROE(3y)1.24%
ROE(5y)9.12%
ROIC(3y)6.93%
ROIC(5y)6.24%
ECCV Yearly ROA, ROE, ROICECCV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

In the last couple of years the Profit Margin of ECCV has declined.
ECCV's Operating Margin has improved in the last couple of years.
In the last couple of years the Gross Margin of ECCV has grown nicely.
Industry RankSector Rank
OM 60.46%
PM (TTM) N/A
GM 63.17%
OM growth 3Y5.72%
OM growth 5Y2.96%
PM growth 3Y-33.04%
PM growth 5YN/A
GM growth 3Y3%
GM growth 5Y2.17%
ECCV Yearly Profit, Operating, Gross MarginsECCV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

More info and screens

3

2. Health

2.1 Basic Checks

ECCV has more shares outstanding than it did 1 year ago.
ECCV has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ECCV has a worse debt to assets ratio.
ECCV Yearly Shares OutstandingECCV Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ECCV Yearly Total Debt VS Total AssetsECCV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

ECCV has an Altman-Z score of 3.86. This indicates that ECCV is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.38 indicates that ECCV is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 3.86
ROIC/WACCN/A
WACCN/A
ECCV Yearly LT Debt VS Equity VS FCFECCV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

ECCV has a Current Ratio of 2.22. This indicates that ECCV is financially healthy and has no problem in meeting its short term obligations.
ECCV has a Quick Ratio of 2.22. This indicates that ECCV is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.22
Quick Ratio 2.22
ECCV Yearly Current Assets VS Current LiabilitesECCV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

5

3. Growth

3.1 Past

ECCV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.73%.
Measured over the past years, ECCV shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.24% on average per year.
ECCV shows a strong growth in Revenue. In the last year, the Revenue has grown by 29.26%.
Measured over the past years, ECCV shows a very strong growth in Revenue. The Revenue has been growing by 22.03% on average per year.
EPS 1Y (TTM)-22.73%
EPS 3Y-5.35%
EPS 5Y-2.24%
EPS Q2Q%-35.29%
Revenue 1Y (TTM)29.26%
Revenue growth 3Y26.64%
Revenue growth 5Y22.03%
Sales Q2Q%14.54%

3.2 Future

The Earnings Per Share is expected to decrease by -9.64% on average over the next years.
Based on estimates for the next years, ECCV will show a quite strong growth in Revenue. The Revenue will grow by 16.22% on average per year.
EPS Next Y-12.57%
EPS Next 2Y-9.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.04%
Revenue Next 2Y16.22%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ECCV Yearly Revenue VS EstimatesECCV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
ECCV Yearly EPS VS EstimatesECCV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 22.96 indicates a rather expensive valuation of ECCV.
The average S&P500 Price/Earnings ratio is at 26.73. ECCV is around the same levels.
Based on the Price/Forward Earnings ratio of 24.51, the valuation of ECCV can be described as rather expensive.
ECCV is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 34.61, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.96
Fwd PE 24.51
ECCV Price Earnings VS Forward Price EarningsECCV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ECCV Per share dataECCV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

A cheap valuation may be justified as ECCV's earnings are expected to decrease with -9.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.64%
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

ECCV has a Yearly Dividend Yield of 5.74%, which is a nice return.
ECCV's Dividend Yield is rather good when compared to the S&P500 average which is at 2.39.
Industry RankSector Rank
Dividend Yield 5.74%

5.2 History

ECCV has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
ECCV Yearly Dividends per shareECCV Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

The earnings of ECCV are negative and hence is the payout ratio. ECCV will probably not be able to sustain this dividend level.
DP-326.46%
EPS Next 2Y-9.64%
EPS Next 3YN/A
ECCV Yearly Income VS Free CF VS DividendECCV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M -400M

More info and screens

EAGLE POINT CREDIT CO - ECC 5 3/8 01/31/29

NYSE:ECCV (8/13/2025, 4:15:00 PM)

23.4142

0 (-0.01%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-12 2025-08-12/bmo
Earnings (Next)11-12 2025-11-12/bmo
Inst Owners8.61%
Inst Owner ChangeN/A
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap2.81B
Analysts77.78
Price Target28.24 (20.61%)
Short Float %0%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield 5.74%
Yearly Dividend1.74
Dividend Growth(5Y)N/A
DP-326.46%
Div Incr Years2
Div Non Decr Years2
Ex-Date06-16 2025-06-16 (0.3359)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.14%
Min EPS beat(2)-13.9%
Max EPS beat(2)3.62%
EPS beat(4)2
Avg EPS beat(4)-5.6%
Min EPS beat(4)-13.9%
Max EPS beat(4)3.62%
EPS beat(8)3
Avg EPS beat(8)-6.78%
EPS beat(12)4
Avg EPS beat(12)-7.9%
EPS beat(16)6
Avg EPS beat(16)-5.88%
Revenue beat(2)0
Avg Revenue beat(2)-1.13%
Min Revenue beat(2)-1.41%
Max Revenue beat(2)-0.85%
Revenue beat(4)1
Avg Revenue beat(4)-1.27%
Min Revenue beat(4)-6.65%
Max Revenue beat(4)3.83%
Revenue beat(8)3
Avg Revenue beat(8)-1.05%
Revenue beat(12)6
Avg Revenue beat(12)-1.21%
Revenue beat(16)9
Avg Revenue beat(16)0.08%
PT rev (1m)10.38%
PT rev (3m)4.26%
EPS NQ rev (1m)-0.81%
EPS NQ rev (3m)-4.65%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.99%
Revenue NQ rev (1m)-0.55%
Revenue NQ rev (3m)-0.65%
Revenue NY rev (1m)-0.63%
Revenue NY rev (3m)-0.53%
Valuation
Industry RankSector Rank
PE 22.96
Fwd PE 24.51
P/S 14.74
P/FCF N/A
P/OCF N/A
P/B 2.76
P/tB 2.76
EV/EBITDA N/A
EPS(TTM)1.02
EY4.36%
EPS(NY)0.96
Fwd EY4.08%
FCF(TTM)-3.37
FCFYN/A
OCF(TTM)-3.37
OCFYN/A
SpS1.59
BVpS8.47
TBVpS8.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.6%
ROE -5.15%
ROCE 8.2%
ROIC 6.48%
ROICexc 6.48%
ROICexgc 6.48%
OM 60.46%
PM (TTM) N/A
GM 63.17%
FCFM N/A
ROA(3y)1.32%
ROA(5y)6.59%
ROE(3y)1.24%
ROE(5y)9.12%
ROIC(3y)6.93%
ROIC(5y)6.24%
ROICexc(3y)7.33%
ROICexc(5y)6.51%
ROICexgc(3y)7.34%
ROICexgc(5y)6.51%
ROCE(3y)8.78%
ROCE(5y)7.89%
ROICexcg growth 3Y7.57%
ROICexcg growth 5Y-0.43%
ROICexc growth 3Y7.47%
ROICexc growth 5Y-0.49%
OM growth 3Y5.72%
OM growth 5Y2.96%
PM growth 3Y-33.04%
PM growth 5YN/A
GM growth 3Y3%
GM growth 5Y2.17%
F-Score0
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 5.48
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.22
Quick Ratio 2.22
Altman-Z 3.86
F-Score0
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.73%
EPS 3Y-5.35%
EPS 5Y-2.24%
EPS Q2Q%-35.29%
EPS Next Y-12.57%
EPS Next 2Y-9.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)29.26%
Revenue growth 3Y26.64%
Revenue growth 5Y22.03%
Sales Q2Q%14.54%
Revenue Next Year22.04%
Revenue Next 2Y16.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25.8%
EBIT growth 3Y33.88%
EBIT growth 5Y25.64%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-531.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-531.18%
OCF growth 3YN/A
OCF growth 5YN/A